Primary |
Product Used For Unknown Indication |
20.1% |
Hypercholesterolaemia |
18.9% |
Blood Cholesterol Increased |
13.8% |
Hypertension |
7.5% |
Blood Cholesterol |
5.7% |
Diabetes Mellitus |
5.0% |
Hyperlipidaemia |
5.0% |
Pain |
4.4% |
Coronary Artery Disease |
3.1% |
Ischaemic Stroke |
3.1% |
Benign Prostatic Hyperplasia |
2.5% |
Arthritis |
1.9% |
Angina Pectoris |
1.3% |
Cardiac Valve Disease |
1.3% |
Chronic Obstructive Pulmonary Disease |
1.3% |
Idiopathic Thrombocytopenic Purpura |
1.3% |
Lipids Increased |
1.3% |
Low Density Lipoprotein Increased |
1.3% |
Arteriosclerosis |
0.6% |
Asthenia |
0.6% |
|
Rhabdomyolysis |
26.7% |
Myopathy |
6.7% |
Pain In Extremity |
6.7% |
Drug Interaction |
5.3% |
Myalgia |
5.3% |
Overdose |
5.3% |
Weight Decreased |
5.3% |
Muscular Weakness |
4.0% |
Renal Failure Acute |
4.0% |
Urinary Tract Infection |
4.0% |
Abasia |
2.7% |
Abdominal Pain Upper |
2.7% |
Arthralgia |
2.7% |
Asthenia |
2.7% |
Completed Suicide |
2.7% |
Hepatitis |
2.7% |
Hypersensitivity |
2.7% |
Liver Injury |
2.7% |
Muscle Injury |
2.7% |
Muscle Spasms |
2.7% |
|
Secondary |
Blood Cholesterol Increased |
25.6% |
Hypercholesterolaemia |
22.7% |
Drug Use For Unknown Indication |
13.9% |
Hypertension |
4.8% |
Blood Triglycerides Increased |
3.3% |
Hyperlipidaemia |
3.3% |
Low Density Lipoprotein Increased |
3.3% |
Pain |
2.9% |
Product Used For Unknown Indication |
2.9% |
Suicidal Ideation |
2.9% |
Lipids Increased |
2.2% |
Cardiac Disorder |
1.8% |
Sleep Disorder |
1.8% |
Angina Pectoris |
1.5% |
Blood Cholesterol |
1.5% |
Depression |
1.5% |
Thyroid Disorder |
1.5% |
Anxiety |
1.1% |
Anticoagulant Therapy |
0.7% |
Asthma |
0.7% |
|
Nervous System Disorder |
14.5% |
Rhabdomyolysis |
13.2% |
Completed Suicide |
9.2% |
Vertigo |
7.9% |
Muscle Spasms |
6.6% |
Wrong Technique In Drug Usage Process |
6.6% |
Burning Sensation |
5.3% |
Myalgia |
5.3% |
Blood Cholesterol Increased |
3.9% |
Drug Hypersensitivity |
3.9% |
Vomiting |
3.9% |
Drug Toxicity |
2.6% |
Myocardial Infarction |
2.6% |
Pain In Extremity |
2.6% |
Retinal Degeneration |
2.6% |
Spinal Operation |
2.6% |
Weight Decreased |
2.6% |
Alopecia |
1.3% |
Anxiety |
1.3% |
Arthralgia |
1.3% |
|
Concomitant |
Product Used For Unknown Indication |
24.5% |
Drug Use For Unknown Indication |
17.7% |
Hypertension |
9.3% |
Blood Cholesterol Increased |
6.3% |
Depression |
5.1% |
Osteoporosis |
4.7% |
Diabetes Mellitus |
3.3% |
Hormone Replacement Therapy |
3.2% |
Blood Cholesterol |
3.0% |
Pain |
3.0% |
Anxiety |
2.9% |
Arthritis |
2.2% |
Breast Cancer Metastatic |
2.2% |
Parkinson's Disease |
2.1% |
Multiple Myeloma |
2.0% |
Type 2 Diabetes Mellitus |
1.9% |
Hypercholesterolaemia |
1.8% |
Asthma |
1.8% |
Menopause |
1.6% |
Myocardial Infarction |
1.6% |
|
Weight Decreased |
15.8% |
Vomiting |
14.7% |
Weight Increased |
9.5% |
Type 2 Diabetes Mellitus |
6.7% |
Death |
4.6% |
Myocardial Infarction |
4.6% |
Pain |
4.6% |
Vision Blurred |
4.2% |
Nausea |
3.9% |
Oedema |
3.5% |
Somnolence |
3.5% |
Drug Ineffective |
3.2% |
Pain In Extremity |
3.2% |
Urinary Tract Infection |
3.2% |
Muscle Spasms |
2.8% |
Oedema Peripheral |
2.8% |
Thrombosis |
2.5% |
Ventricular Extrasystoles |
2.5% |
White Blood Cell Count Increased |
2.5% |
Depression |
2.1% |
|
Interacting |
Type 2 Diabetes Mellitus |
100.0% |
|
|